Differential effects of isoliquiritigenin and YC-1 in rat aortic smooth muscle
- 1 March 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 323 (1) , 89-91
- https://doi.org/10.1016/s0014-2999(97)00111-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.Proceedings of the National Academy of Sciences, 1996
- YC‐1 inhibited human platelet aggregation through NO‐independent activation of soluble guanylate cyclaseBritish Journal of Pharmacology, 1995
- Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aortaBritish Journal of Pharmacology, 1995
- Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583.Stroke, 1993
- Inhibition of nitric oxide synthesis by methylene blueBiochemical Pharmacology, 1993
- Inhibition of Adenosine 3', 5'-Cyclic Monophosphate Phosphodiesterase by Flavonoids from Licorice Roots and 4-ArylcoumarinsCHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- Biosynthesis and Metabolism of Endothelium-Derived Nitric OxideAnnual Review of Pharmacology and Toxicology, 1990
- Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin‐stimulated production of prostacyclin by pig aortic endothelial cellsBritish Journal of Pharmacology, 1989
- Independent blockade of cerebral vasodilation from acetylcholine and nitric oxideAmerican Journal of Physiology-Heart and Circulatory Physiology, 1988